The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
- Hamamatsu Photonics
- 360 Foothill Rd.
- Bridgewater NJ, 08807
- UNITED STATES
Hamamatsu has been working with the Photon for more than 50 years. We have established ourselves as the top company of photoelectron conversion technologies in the world. However, we have yet to fully grasp the nature of the Photon and its potential. The more you study, the more you realize how little you know about the Photon and its applications. That is why we continue to move ahead vigorously with basic research and apply what we learn to photonics.